scholarly journals Influence of Primary Care Physician Availability and Socioeconomic Deprivation on Breast Cancer from 1988 to 2008: A Spatio-Temporal Analysis

PLoS ONE ◽  
2012 ◽  
Vol 7 (4) ◽  
pp. e35737 ◽  
Author(s):  
Lung-Chang Chien ◽  
Anjali D. Deshpande ◽  
Donna B. Jeffe ◽  
Mario Schootman
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Primary Care Physician ◽  
Temporal Analysis ◽  
Care Physician ◽  
Socioeconomic Deprivation ◽  
Spatio Temporal ◽  
Physician Availability

Review of Breast Screening Guidelines and Disease Management for the Primary Care Physician

2016 ◽  
Vol 2 (8) ◽  
Author(s):  
Linda M Sanders
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Primary Care Physician ◽  
Breast Density ◽  
Task Force ◽  
Nipple Discharge ◽  
The United States ◽  
Care Physician ◽  
Masking Effect ◽  
Screening Guidelines

This review article discusses the most recent recommendations for screening for breast cancer issued by the United States Preventitive Services Task Force in January 2016 and the criticisms of those recommendations.   This article also reviews the most common breast complaints seen by the primary care physician, including the inflamed breast, palpable concerns, and nipple discharge.  Included is a discussion of "the dense breast" which has become a national issue.  28 states have passed breast density laws designed to raise awareness of the masking effect of increased breast density on mammogram on the detection of breast cancer.

A new paradigm for patient-centered breast cancer care.

2016 ◽  
Vol 34 (3_suppl) ◽  
pp. 46-46
Author(s):  
Kristina M Diaz ◽  
Edward Paul ◽  
Gregory John C. Yang ◽  
Shirley Phillips ◽  
John Bowles ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Cancer Treatment ◽  
Primary Care Physician ◽  
Cancer Care ◽  
Current Model ◽  
Care Physician ◽  
Breast Cancer Care ◽  
New Model ◽  
Primary Physician

46 Background: The active role of a primary care physician has been shown to improve outcomes for patients in all areas of health management. Cancer care is rapidly evolving as a result of major advances in cancer genomics and the production of new, mostly oral, chemotherapeutic agents targeted to specific patients. The estimated number of cancer survivors is expected to dramatically increase in the next decade. One good example of a new model of cancer care that relies upon the steady presence and involvement of the primary care physician is the care of patients with non-metastatic breast cancer. The current model of breast cancer care includes the primary physician identifying a lesion, obtaining required imaging, making a preliminary diagnosis of presumptive breast cancer, referring to the surgeon and/or oncologist, then resuming care of the patient post survivorship. In the new model of care described here, oncologists play a peripheral role and once therapy is initiated, care by the primary care physician in an integrated, team-oriented, system becomes ideal. Methods: Via a shared care model in which the primary physician is trained to provide direct oncologic care for the patient. They will thereafter initiate a survivor plan that will allow the patient to return to their own medical ecosystem with the least delay and compromise. The primary physician is anticipated to actively direct care for the cancer patient including prescribing recommended cancer treatment, managing medication side effects, and making appropriate referrals when necessary. Results: see below Conclusions: There is good evidence that outcomes by a primary care physician throughout the entire breast cancer treatment phase are comparable to care provided by oncologists in the current model. When the primary care physician is given the right tools and empowered to lead the care for the patient, improved compliance, improved psychosocial quality, and appropriate survivorship follow up can be achieved. With the ability to care for all aspects of their patient’s needs, both biomedical and emotional, the primary physician can, and should, start taking a more active and holistic role in providing care for their patients. Never was this more true then now.

Integrating the primary care physician into cancer follow-up.

2016 ◽  
Vol 34 (3_suppl) ◽  
pp. 102-102 ◽  
Author(s):  
Andrew L. Salner ◽  
Deborah Walker ◽  
Amanda Seltzer ◽  
SarahLena Panzer ◽  
Carrie Stricker ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Primary Care Physician ◽  
Care Physician ◽  
Care Plan ◽  
Survivorship Care Plan ◽  
Survivorship Care ◽  
Care Plans ◽  
Follow Up Care

102 Background: After a diagnosis of breast cancer, it can be difficult for patients to understand the role their primary care physician (PCP) should play in their follow up care. Methods: 65 women (mean age 60 years, SD = 10) with breast cancer (stage 0-III) were seen by a nurse practitioner for a 60-90 minute consultative survivorship visit and received a treatment summary and personalized survivorship care plan (SCP) utilizing Carevive Care Planning Systems software. The Carevive system incorporates patient-reported and clinical data to create tailored care plans with personalized recommendations for follow up care and supportive referrals, including direction to follow up with primary care for specific care and health maintenance activities. Approximately 6 weeks following their survivorship care visit, patients completed a survey assessing their use of and satisfaction with the SCP. Patients were advised that the SCP would be mailed to their referring oncologist and primary care physician. Results: Out of 65 sent, 35 surveys have been completed to date. Survivors were diagnosed approximately 10 months prior, and all were within 6 months following completion of treatment. All patients (100%) reported that they read, or planned to read, their survivorship care plan packet carefully. While all care plans included a recommendation to follow up with their PCP, only (71%) of survivors remembered receiving this recommendation. Of those who did, most (74%) had either seen or scheduled an appointment with their PCP. Patients who reported higher anxiety at the time of the survivorship visit were more likely to report that the follow up care plan helped them take action about seeing their PCP (p = .03). Conclusions: Coordination between primary and oncology care providers has previously been shown to improve the quality of care for cancer survivors. SCPs that emphasize the importance of and activities to be undertaken in primary care may help to improve this coordination. Continuation of this research will help to better understand how to integrate the primary care physician into cancer follow up care. Updated data will be shared at time of presentation.

scholarly journals A rare cancer in men is breast cancer. The importance of long-term monitoring of the primary care physician status (based on own observations)

2020 ◽  
Vol 0 (1 (237)) ◽  
pp. 61-66
Author(s):  
V. M. Rudichenko ◽  
N. G. Karbivnycha ◽  
A. V. Kushneryk ◽  
G. M. Vynogradova ◽  
V. I. Byk ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Primary Care Physician ◽  
Care Physician ◽  
Rare Cancer ◽  
Long Term Monitoring ◽  
Term Monitoring

scholarly journals Caring for survivors of breast cancer: perspective of the primary care physician

2011 ◽  
Vol 18 (5) ◽  
Author(s):  
S. L. Smith ◽  
E. S. Wai ◽  
C. Alexander ◽  
S. Singh-Carlson
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Primary Care Physician ◽  
Care Physician

scholarly journals Endocrine therapy for breast cancer in the primary care setting

2018 ◽  
Vol 25 (4) ◽  
Author(s):  
A. Awan ◽  
A. Esfahani
Keyword(s):  
Breast Cancer ◽  
Primary Care ◽  
Estrogen Receptor ◽  
Endocrine Therapy ◽  
Primary Care Physician ◽  
Hormonal Therapy ◽  
Routine Care ◽  
Care Physician ◽  
The Past ◽  
Estrogen Receptor Modulators

The treatment of hormone-positive breast cancer (bca) is a rapidly evolving field. Improvement in the understanding of the mechanisms of action and resistance to anti-hormonal therapy has translated, in the past decade, into multiple practice-changing clinical trials, with the end result of increased survivorship for patients with all stages of hormone-positive cancer. The primary care physician will thus play an increasing role in the routine care, surveillance, and treatment of issues associated with anti-hormonal therapy. The aim of the present review was to provide a focused description of the issues relevant to primary care, while briefly highlighting recent advances in the field of anti-hormonal therapy.Key PointsHormone-positive bca is the most prevalent form of bca and, compared with the other subtypes, is usually associated with better survival.Survivorship has significantly increased for all stages of hormone-positive bca, making the primary care physician a key player in the care of affected patients.The two most common classes of anti-hormonal agents used in these patients are selective estrogen receptor modulators and aromatase inhibitors. Each class of medication is associated with signature side effects.Within the past decade, multiple novel estrogen receptor blockers (for example, fulvestrant) and agents aimed at circumventing resistance to endocrine therapy [inhibitors of cyclin-dependent kinase 4/6 and of mtor (the mechanistic target of rapamycin)] have gained clinical ground. Understanding their side effects will be increasingly relevant to primary care physicians.Multidisciplinary care is always encouraged in the care of cancer patients receiving anti-hormonal therapy.

Sign in / Sign up

Export Citation Format

Share Document